Navigation Links
Gene Predicts Breast Cancer Prognosis
Date:4/23/2008

Experiments in mice could lead to better diagnosis and treatment, experts say

WEDNESDAY, April 23 (HealthDay News) -- A protein that stops the spread of breast cancer tumors in mice can predict which malignancies might spread, a new study suggests.

The gene, called bromodomain protein (Brd4), when added to breast cancer cells in mice, produced a unique gene signature, which was also detected in human breast cancer patients.

"We have identified that this particular gene seems to be associated with outcomes in breast cancer," said lead researcher Kent W. Hunter, a senior investigator at the U.S. National Cancer Institute. "This gene may be something we want to investigate in more detail."

Understanding how the new gene functions may lead to a better understanding of what makes breast cancer metastasize, Hunter said. "This will help identify patients who will have a better or worse outcome," he added.

The report was published in this week's issue of the Proceedings of the National Academy of Sciences.

In the study, Hunter's team inserted the gene for the Brd4 proteins into mouse breast cancer tumor cells that are known for their ability to metastasize.

However, tumor cells that contained Brd4 produced smaller tumors that did not metastasize as readily. In addition, Brd4 changed many other genes, resulting in a unique genetic signature.

The researchers then mapped the signature genes to corresponding human genes, and compared the human Brd4 signature with patient data from five large groups of breast cancer patients.

In all five groups, those patients who had the Brd4-positive signature lived longer and had a lower incidence of metastatic tumors, the researchers found. This indicates that the Brd4 gene expression signatures could accurately predict the severity of breast cancer, the researchers said.

These findings may lead to new treatments, Hunter said.

"We may not only be able to find a prognostic signature, but we can identify other genetic elements that are driving prognosis, so we may also be able to develop additional therapeutic strategies," Hunter said. "We may be able to find new drugs or strategies to improve quality of life and extend life span."

One expert doesn't think this gene makes a contribution to predicting the prognosis of breast cancer.

"This is a marker study looking at a novel gene and its expression, and suggests that the gene expression may predict outcome in node-negative, estrogen-positive breast cancer," said Dr. Harold J. Burstein, an assistant professor of medicine at Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School.

"There are already multiple, commercially available gene expression array tests such as Oncotype DX, MammaPrint, with more extensive clinical support for similar patients," Burstein said. "Most investigators believe that multiple gene assays are more informative than single gene assays."

"Finally, the clinical validation in this experience is drawn from small sets of patients, and the strength of the data suggest modest, if any, real contribution for this gene," Burstein said.

More information

For more on breast cancer, visit the U.S. National Cancer Institute.



SOURCES: Kent W. Hunter, Ph.D., senior investigator, U.S. National Cancer Institute, Bethesda, Md.; Harold J. Burstein, M.D., Ph.D., assistant professor, medicine, Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston; April 21-25, 2008, Proceedings of the National Academy of Sciences


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New ViziLite Plus Could Reduce Oral Cancer Fatalities Predicts East Bays Creative Dimensions in Dentistry
2. Early neglect predicts aggressive behavior in children
3. 10 Million Baby Boomers Face Alzheimers, Report Predicts
4. New Test Predicts Risk of Post-Surgery Kidney Injury
5. Bacteria Mix in Guts of Babies Predicts Obesity
6. Genetic Test Predicts Response to Warfarin
7. Health and Fashion - Dow Corning Predicts the Top Trends Driving Consumers to the Beauty Counters
8. U.S. Health Care Spending to Double by 2017, Report Predicts
9. Novel mathematical model predicts new wave of drug-resistant HIV infections in San Francisco
10. Gene variant predicts medication response in patients with alcohol dependence
11. Gene predicts heart attack response and cardiac damage
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gene Predicts Breast Cancer Prognosis
(Date:10/13/2017)... ... 13, 2017 , ... While it’s often important to take certain medications during ... Austin, Texas, has identified a solution. , She developed a prototype for MOTION LIGHT-UP ... such, it eliminates the need to turn on a light when taking medication during ...
(Date:10/13/2017)... ... , ... Lori R. Somekh, founder of the Law Office of Somekh ... law and special needs planning attorneys. “Membership in ElderCounsel helps our office remain up ... network with elder law attorneys nationwide,” said Somekh. , ElderCounsel was ...
(Date:10/13/2017)... ... 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought ... This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at ... towards children of all ages; it is a non-competitive, non-timed event, which is all ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one ... an innovative new design of the shoulder pad. The shoulder pad provides optimal ... controlling your pain while using cold therapy. By utilizing ice and water that is ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 2017  EpiVax, Inc., a leader in the ... today announced the launch of EpiVax Oncology Inc., ... therapeutic cancer vaccines. EpiVax has provided $500,000 in ... enabling technologies to the new precision immunotherapy venture. ... Oncology as Chief Executive Officer. Gad brings over ...
(Date:9/19/2017)... Sept. 19, 2017   ZirMed Inc ., a recognized ... announced that it has been ranked #1 by its users ... Rankings 2017 User Survey. ZirMed was recognized as the ... hospitals and medical centers over 200 beds and holds one ... technology user survey history. ...
(Date:9/12/2017)... -- Consumer reviews on the independent review site Consumer Affairs ... for hearing aids, ranking it higher than Miracle Ear ™, ... ... Hearing Aids ... store that provides high performance, state-of-the-art, German-engineered hearing aids directly to ...
Breaking Medicine Technology: